Ralf D. Hofheinz

Mannheim, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial.

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial.

Journal: Nature communications

Published: April 17, 2026

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

Journal: Cancer research communications

Published: October 15, 2025

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial.

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial.

Journal: Nature communications

Published: July 01, 2025

HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments.

HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments.

Journal: Cancers

Published: February 07, 2024

HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research.

HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research.

Journal: Cancers

Published: June 19, 2023

Oncology in Europe.

Oncology in Europe.

Journal: Oncology research and treatment

Published: February 13, 2023

Multimodal Treatment of Rectal Cancer.

Multimodal Treatment of Rectal Cancer.

Journal: Deutsches Arzteblatt international

Published: March 03, 2022

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.

Journal: The lancet. Healthy longevity

Published: February 28, 2022

Gender aspects in cardiooncology.

Gender aspects in cardiooncology.

Journal: European journal of public health

Published: September 13, 2021

International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.

International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.

Journal: Nature reviews. Clinical oncology

Published: June 16, 2021

Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society.

Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society.

Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Published: December 16, 2020

Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology.

Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology.

Journal: Anticancer research

Published: November 15, 2020

Showing 1-12 of 42

Last Updated: 09/26/2026